belimumab (benlysta) Report issue

Biologics mAb Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH repoDB
Back

Drug Pricing Summary

VA Big4

$385.0700 - $1280.2200

VA FSS

$518.4600 - $1728.1400

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
belimumab 120 mg / 1.5 mL (1.5 mL INJECTION) $385.0700 VA Big4
  • BENLYSTA (1)
    		•  GlaxoSmithKline
    belimumab 120 mg / 1.5 mL (1.5 mL INJECTION) $518.4600 VA FSS
  • BENLYSTA (1)
    		•  GlaxoSmithKline
    belimumab 200 mg / 1 mL (1 mL SOLUTION) $675.0900 VA Big4
  • BENLYSTA (4)
    		•  GlaxoSmithKline
    belimumab 200 mg / 1 mL (1 mL SOLUTION) $676.2800 VA Big4
  • BENLYSTA (4)
    		•  GlaxoSmithKline
    belimumab 200 mg / 1 mL (1 mL SOLUTION) $907.3775 VA FSS
  • BENLYSTA (4)
    		•  GlaxoSmithKline
  • BENLYSTA (4)
    		•  GlaxoSmithKline
    belimumab 400 mg / 5 mL (5 mL INJECTION) $1280.2200 VA Big4
  • BENLYSTA (1)
    		•  GlaxoSmithKline
    belimumab 400 mg / 5 mL (5 mL INJECTION) $1728.1400 VA FSS
  • BENLYSTA (1)
    		•  GlaxoSmithKline

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue